A TECHNICAL COMPARISON BETWEEN IGH AND BCL1/IGH MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE ANALYSIS IN MANTLE CELL LYMPHOMA

被引：0
|
作者：
Ghione, P. [1 ]
Monitillo, L. [1 ]
Barbero, D. [1 ]
Verardo, G. [1 ]
Drandi, D. [1 ]
Grimaldi, D. [1 ]
Genuardi, E. [1 ]
Mantoan, B. [1 ]
Cavallo, F. [1 ]
Vasta, M. [1 ]
Zaja, F. [2 ]
Visco, C. [3 ]
Cortelazzo, S. [4 ]
Boccadoro, M. [1 ]
Ladetto, M. [5 ]
Ferrero, S. [1 ]
机构：
[1] Univ Torino, Div Hematol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy
[2] AOUD SM Misericordia, Hematol, DISM, Piazzale Santa Maria della Misericordia, Udine, Italy
[3] S Bortolo Hosp, Dept Hematol, Vicenza, Italy
[4] Clin Humanitas Gavazzeni, Unita Oncol, Bergamo, Italy
[5] Azienda Osped SS Antonio & Biagio & Cesare Arrigo, Alessandria, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C057
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [1] SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?
    Simonsen, Anita T.
    Schou, Marie
    Sorensen, Camilla D.
    Bentzen, Hans H. N.
    Nyvold, Charlotte G.
    LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2724 - 2727
  • [2] SOX11, CCND1, BCL1/Igh, and Igh-VDJ - a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?
    Simonsen, Anita Tranberg
    Schou, Marie
    Sorensen, Camilla Darum
    Hokland, Peter
    Bentzen, Hans
    Nyvold, Charlotte Guldborg
    BLOOD, 2014, 124 (21)
  • [3] Potential molecular mechanism of bcl-1/IgH gene rearrangement in mantle cell lymphoma.
    Sun, WJ
    Lin, MF
    Kellner, U
    Parwaresch, R
    BLOOD, 2002, 100 (11) : 286B - 286B
  • [4] Serum BCL2/IGH DNA in follicular lymphoma patients:: A minimal residual disease marker
    Gocke, CD
    Kopreski, MS
    Benko, FA
    Sternas, L
    Kwak, LW
    LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 165 - 172
  • [5] Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation
    Stamatopoulos, K
    Kosmas, C
    Belessi, C
    Kyriazopoulos, P
    Papadaki, T
    Anagnostou, D
    Loukopoulos, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (01) : 190 - 197
  • [6] Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas
    Pott, C
    Tiemann, M
    Linke, B
    Ott, MM
    von Hofen, M
    Bolz, I
    Hiddemann, W
    Parwaresch, R
    Kneba, M
    LEUKEMIA, 1998, 12 (10) : 1630 - 1637
  • [7] Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas
    C Pott
    M Tiemann
    B Linke
    MM Ott
    M von Hofen
    I Bolz
    W Hiddemann
    R Parwaresch
    M Kneba
    Leukemia, 1998, 12 : 1630 - 1637
  • [8] Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing
    Wu, Jinghua
    Jia, Shan
    Wang, Changxi
    Zhang, Wei
    Liu, Sixi
    Zeng, Xiaojing
    Mai, Huirong
    Yuan, Xiuli
    Du, Yuanping
    Wang, Xiaodong
    Hong, Xueyu
    Li, Xuemei
    Wen, Feiqiu
    Xu, Xun
    Pan, Jianhua
    Li, Changgang
    Liu, Xiao
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [9] MOLECULAR ANALYSIS COMBINED WITH MYC-IGH AND IG REARRANGEMENT FOR THE EVALUATION OF MINIMAL RESIDUAL DISEASE IN MATURE CELL B LEUKEMIA
    Mussolin, L.
    Lovisa, F.
    Pillon, M.
    Corral, L.
    Cazzaniga, G.
    Piglione, M.
    Lippi, A.
    Mura, R.
    Favre, C.
    Lo Nigro, L.
    Arcamone, G.
    Biondi, A.
    Rosolen, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : S26 - S26
  • [10] Minimal Residual Disease Detection in Mantle Cell Lymphoma: Technical Aspects and Clinical Relevance
    Pott, Christiane
    SEMINARS IN HEMATOLOGY, 2011, 48 (03) : 172 - 184
12345